Insider Transactions in Q1 2022 at Selecta Biosciences Inc (SELB)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 02
2022
|
Carsten Brunn President and CEO |
SELL
Open market or private sale
|
Direct |
5,443
-1.03%
|
$5,443
$1.81 P/Share
|
|
Mar 01
2022
|
Carsten Brunn President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,937
+2.03%
|
-
|
|
Jan 14
2022
|
Timothy C Barabe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.76%
|
$20,000
$2.1 P/Share
|
|
Jan 05
2022
|
Carsten Brunn President and CEO |
SELL
Open market or private sale
|
Direct |
13,597
-2.56%
|
$40,791
$3.09 P/Share
|
|
Jan 05
2022
|
Lloyd P. Johnston Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
3,416
-1.91%
|
$10,248
$3.09 P/Share
|
|
Jan 05
2022
|
Takashi Kei Kishimoto Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,416
-1.26%
|
$10,248
$3.09 P/Share
|
|
Jan 05
2022
|
Peter G Traber Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,226
-1.27%
|
$9,678
$3.09 P/Share
|
|
Jan 03
2022
|
Carsten Brunn President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
226,300
+29.86%
|
-
|
|
Jan 03
2022
|
Lloyd P. Johnston Chief Operations Officer |
BUY
Grant, award, or other acquisition
|
Direct |
72,000
+28.72%
|
-
|
|
Jan 03
2022
|
Takashi Kei Kishimoto Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
72,000
+20.94%
|
-
|
|
Jan 03
2022
|
Kevin Tan Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
72,000
+48.32%
|
-
|
|
Jan 03
2022
|
Peter G Traber Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
90,200
+26.16%
|
-
|